182 related articles for article (PubMed ID: 31674724)
21. Prevalence of leukoencephalopathy and its potential cognitive sequelae in cancer patients.
Schroyen G; Meylaers M; Deprez S; Blommaert J; Smeets A; Jacobs S; Sunaert S; Sleurs C; Uyttebroeck A
J Chemother; 2020 Nov; 32(7):327-343. PubMed ID: 32799637
[TBL] [Abstract][Full Text] [Related]
22. Successful treatment without cranial radiotherapy of children receiving intensified chemotherapy for acute lymphoblastic leukaemia: results of the risk-stratified randomized central nervous system treatment trial MRC UKALL XI (ISRC TN 16757172).
Hill FG; Richards S; Gibson B; Hann I; Lilleyman J; Kinsey S; Mitchell C; Harrison CJ; Eden OB;
Br J Haematol; 2004 Jan; 124(1):33-46. PubMed ID: 14675406
[TBL] [Abstract][Full Text] [Related]
23. Study of Posterior Reversible Encephalopathy Syndrome in Children With Acute Lymphoblastic Leukemia After Induction Chemotherapy.
Tang JH; Tian JM; Sheng M; Hu SY; Li Y; Zhang LY; Gu Q; Wang Q
J Child Neurol; 2016 Mar; 31(3):279-84. PubMed ID: 26060305
[TBL] [Abstract][Full Text] [Related]
24. Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.
Chessells JM; Harrison CJ; Watson SL; Vora AJ; Richards SM;
Br J Haematol; 2002 May; 117(2):306-14. PubMed ID: 11972512
[TBL] [Abstract][Full Text] [Related]
25. Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study.
Guzelkucuk Z; Karapınar DY; Gelen SA; Tokgoz H; Ozcan A; Ay Y; Bahadır A; Ozbek NY; Oren AC; Ayhan AC; Akyay A; Akıncı B; Karadas N; Unuvar A; Oren H; Fettah A; Kaya Z; Isık B; Eker İ; Karaman S; Yıldırım AT; Orhan MF; Oymak Y; Timur C; Yazici N; Simsek A; Karakurt N; Toret E; Evim MS
Pediatr Blood Cancer; 2023 Aug; 70(8):e30425. PubMed ID: 37194482
[TBL] [Abstract][Full Text] [Related]
26. Management of CNS Disease in Pediatric Acute Lymphoblastic Leukemia.
McNeer JL; Schmiegelow K
Curr Hematol Malig Rep; 2022 Feb; 17(1):1-14. PubMed ID: 35025035
[TBL] [Abstract][Full Text] [Related]
27. Dexamethasone-based therapy for childhood acute lymphoblastic leukaemia: results of the prospective Dutch Childhood Oncology Group (DCOG) protocol ALL-9 (1997-2004).
Veerman AJ; Kamps WA; van den Berg H; van den Berg E; Bökkerink JP; Bruin MC; van den Heuvel-Eibrink MM; Korbijn CM; Korthof ET; van der Pal K; Stijnen T; van Weel Sipman MH; van Weerden JF; van Wering ER; van der Does-van den Berg A;
Lancet Oncol; 2009 Oct; 10(10):957-66. PubMed ID: 19747876
[TBL] [Abstract][Full Text] [Related]
28. Patterns and Outcomes of Acute Central Nervous System Complications During Treatment of Childhood Acute Lymphoblastic Leukemia: A Single-center Experience.
Hamoda A; Bedair M; Semary SF; Youssef A; Hafez H
J Pediatr Hematol Oncol; 2024 Mar; 46(2):72-79. PubMed ID: 38132573
[TBL] [Abstract][Full Text] [Related]
29. Central nervous system disease in childhood acute lymphoblastic leukemia: prognostic factors and results of treatment.
Kreuger A; Garwicz S; Hertz H; Jonmundsson G; Lanning M; Lie SO; Moe PJ; Salmi TT; Schröder H; Siimes MA
Pediatr Hematol Oncol; 1991; 8(4):291-9. PubMed ID: 1845651
[TBL] [Abstract][Full Text] [Related]
30. Outcome and toxicities associated to chemotherapy in children with acute lymphoblastic leukemia and Gilbert syndrome. Usefulness of UGT1A1 mutational screening.
Berrueco R; Alonso-Saladrigues A; Martorell-Sampol L; Català-Temprano A; Ruiz-Llobet A; Toll T; Torrebadell M; Naudó M; Camós M; Rives S
Pediatr Blood Cancer; 2015 Jul; 62(7):1195-201. PubMed ID: 25855413
[TBL] [Abstract][Full Text] [Related]
31. Comparison of two schedules of intermediate-dose methotrexate and cytarabine consolidation therapy for childhood B-precursor cell acute lymphoblastic leukemia: a Pediatric Oncology Group study.
Land VJ; Shuster JJ; Crist WM; Ravindranath Y; Harris MB; Krance RA; Pinkel D; Pullen DJ
J Clin Oncol; 1994 Sep; 12(9):1939-45. PubMed ID: 8083715
[TBL] [Abstract][Full Text] [Related]
32. Acute neurotoxicity in children with B-lineage acute lymphoblastic leukemia (B-ALL) treated with intermediate risk protocols.
Lo Nigro L; Di Cataldo A; Schiliro G
Med Pediatr Oncol; 2000 Nov; 35(5):449-55. PubMed ID: 11070476
[TBL] [Abstract][Full Text] [Related]
33. The prognosis and survival of childhood acute lymphoblastic leukemia with central nervous system relapse.
Unal S; Yetgin S; Cetin M; Gümrük F; Arslan D; Ozyürek E; Tuncer M; Topçu M
Pediatr Hematol Oncol; 2004; 21(3):279-89. PubMed ID: 15202168
[TBL] [Abstract][Full Text] [Related]
34. Effective preventive central nervous system therapy with extended triple intrathecal therapy and the modified ALL-BFM 86 chemotherapy program in an enlarged non-high risk group of children and adolescents with non-B-cell acute lymphoblastic leukemia: the Israel National Study report.
Stark B; Sharon R; Rechavi G; Attias D; Ballin A; Cividalli G; Burstein Y; Sthoeger D; Abramov A; Zaizov R
Cancer; 2000 Jan; 88(1):205-16. PubMed ID: 10618625
[TBL] [Abstract][Full Text] [Related]
35. Prevention of CNS recurrence in childhood ALL: results with reduced radiotherapy combined with CNS-directed chemotherapy in four consecutive ALL-BFM trials.
Schrappe M; Reiter A; Henze G; Niemeyer C; Bode U; Kühl J; Gadner H; Havers W; Plüss H; Kornhuber B; Zintl F; Ritter J; Urban C; Niethammer D; Riehm H
Klin Padiatr; 1998; 210(4):192-9. PubMed ID: 9743952
[TBL] [Abstract][Full Text] [Related]
36. Long-term prognosis of children with Down's syndrome and leukaemia: a 34-year nation-wide experience.
Rajantie J; Siimes MA
J Intellect Disabil Res; 2003 Nov; 47(Pt 8):617-21. PubMed ID: 14641809
[TBL] [Abstract][Full Text] [Related]
37. Citrulline as a biomarker of bacteraemia during induction treatment for childhood acute lymphoblastic leukaemia.
De Pietri S; Frandsen TL; Christensen M; Grell K; Rathe M; Müller K
Pediatr Blood Cancer; 2021 Jan; 68(1):e28793. PubMed ID: 33155402
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: influence on cure rates and risk of second cancer.
Levinsen M; Rotevatn EØ; Rosthøj S; Nersting J; Abrahamsson J; Appell ML; Bergan S; Bechensteen AG; Harila-Saari A; Heyman M; Jonsson OG; Maxild JB; Niemi M; Söderhäll S; Schmiegelow K;
Pediatr Blood Cancer; 2014 May; 61(5):797-802. PubMed ID: 24395436
[TBL] [Abstract][Full Text] [Related]
39. Does minimal central nervous system involvement in childhood acute lymphoblastic leukemia increase the risk for central nervous system toxicity?
Anastasopoulou S; Harila-Saari A; Als-Nielsen B; Eriksson MA; Heyman M; Johannsdottir IM; Marquart HV; Niinimäki R; Pronk CJ; Schmiegelow K; Vaitkeviciene G; Thastrup M; Ranta S
Pediatr Blood Cancer; 2022 Jul; 69(7):e29745. PubMed ID: 35488712
[TBL] [Abstract][Full Text] [Related]
40. Central nervous system recurrence in adult patients with acute lymphoblastic leukemia: frequency and prognosis in 467 patients without cranial irradiation for prophylaxis.
Sancho JM; Ribera JM; Oriol A; Hernandez-Rivas JM; Rivas C; Bethencourt C; Parody R; Deben G; Bello JL; Feliu E;
Cancer; 2006 Jun; 106(12):2540-6. PubMed ID: 16700036
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
